Cover Image
市場調查報告書

全球臨床用次世代定序 (NGS) 市場

Global Clinical Next-generation Sequencing Market

出版商 Frost & Sullivan 商品編碼 348162
出版日期 內容資訊 英文 71 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球臨床用次世代定序 (NGS) 市場 Global Clinical Next-generation Sequencing Market
出版日期: 2015年12月24日 內容資訊: 英文 71 Pages
簡介

本報告提供日常診斷用次世代定序 (NGS) 型檢驗的引進相關課題調查分析,基因板及全外顯子定序的新興應用相關的討論,消費者直接形式 (DTC) 檢驗企業簡介,及NGS型遺傳基因檢驗以及主要企業的簡介等彙整。

摘要整理

市場概要

  • 市場展望
  • NGS設備的目前法規情形
  • NGS檢驗的發展
  • NGS臨床應用 vs. 研究應用

市場展望

  • 全球NGS臨床市場展望
  • 中國的NGS臨床形勢
  • 美國的NGS臨床形勢
  • 全球NGS臨床應用的未開發市場
  • 臨床NGS的機會的評估
  • 全球NGS技術的利用
  • NGS型比較診斷:短期性的可能性

醫療費償付範圍的最佳業務實踐

  • 應考慮點
  • 醫療費償付的目前通訊協定
  • 3家公司的成功案例:醫療費償付的促進要素為何?
  • Genomic Health
  • Veracyte
  • Veracyte (Illumina)
  • 醫療費償付範圍的最佳業務實踐的摘要

引進障礙

  • 主要的障礙
  • 來自初期採用者 (早期採用者) 的教訓
  • 臨床NGS的調查
  • 結論、未來展望

附錄:各手法的檢驗趨勢

主要的NGS型檢驗的定價:美國

NGS臨床檢驗提供企業簡介:美國

消費者直接形式 (DTC) 檢驗企業簡介:全球

關於Frost&Sullivan

目錄
Product Code: 9AB9-00-46-00-00

Learn the Emerging Clinical Applications and Best Practices to the Road to Reimbursement

This market insight covers the challenges associated with the adoption of next-generation sequencing (NGS)-based testing for routine diagnostic use. Emerging applications for gene panel and whole exome sequencing are discussed. Best practices and guidance have been provided to attain coverage on newly launched tests through case study analysis. Tables have been provided for select companies providing NGS-based testing for clinical use, pricing of panels, and CAP survey analysis. Profiles of direct-to-consumer testing genetic testing companies are provided in the report.

Table of Contents

1. GLOBAL CLINICAL NEXT-GENERATION SEQUENCING MARKET

Executive Summary

  • 1. Summary

Market Overview

  • 1. Market Outlook
  • 2. Current Regulatory Status of NGS Instruments
  • 3. Evolution of NGS Testing
  • 4. NGS for Clinical versus Research Applications

Market Outlook

  • 1. Market Outlook on NGS Clinical Markets-Global
  • 2. NGS Clinical Landscape-China
  • 3. NGS Clinical Landscape-United States
  • 4. Untapped Market for Clinical Applications of NGS-Global
  • 5. Opportunity Assessment for Clinical NGS
  • 6. Use of NGS Technology-Global
  • 7. NGS-based Companion Diagnostics a Near-term Possibility

Best Practices onReimbursement Coverage

  • 1. Points to Consider
  • 2. Current Protocols for Reimbursement
  • 3. Success Stories of 3 Companies-What Drives Reimbursement?
  • 4. Genomic Health
  • 5. Veracyte
  • 6. Veracyte (Illumina)
  • 7. Summary of Reimbursement Coverage Best Practices

Barriers to Adoption

  • 1. Top Bottlenecks
  • 2. Lessons from Early Adopters
  • 3. Survey on Clinical NGS
  • 4. Survey on Clinical NGS (continued)
  • 5. Key Conclusions and Future Outlook

Appendix-Testing Trends by Method

  • 1. Analysis from the Genetic Test Repository (GTR)
  • 2. Test Purpose
  • 3. Test Method-NGS, Microarray, Sanger, and CGH Based
  • 4. Tests Offered By Location
  • 5. Tests Offered By Location (continued)

List Price of Selected NGS-based Tests-United States

  • 1. Selected NGS-based Tests with Clinical Significance
  • 2. Selected NGS-based Tests with Clinical Significance (continued)
  • 3. Selected NGS-based Tests with Clinical Significance (continued)

Profiles of Companies Offering NGS Clinical Tests-United States

  • 1. NGS Clinical Test Provider Profiles
  • 2. NGS Clinical Test Provider Profiles (continued)
  • 3. NGS Clinical Test Provider Profiles (continued)
  • 4. NGS Clinical Test Provider Profiles (continued)
  • 5. NGS Clinical Test Provider Profiles (continued)
  • 6. NGS Clinical Test Provider Profiles (continued)
  • 7. NGS Clinical Test Provider Profiles (continued)
  • 8. NGS Clinical Test Provider Profiles (continued)
  • 9. NGS Clinical Test Provider Profiles (continued)
  • 10. NGS Clinical Test Provider Profiles (continued)
  • 11. NGS Clinical Test Provider Profiles (continued)

Profiles of Companies Offering Direct-to-consumer Testing-Global

  • 1. List for DTC Genetic Testing
  • 2. List for DTC Genetic Testing (continued)
  • 3. List for DTC Genetic Testing (continued)
  • 4. List for DTC Genetic Testing (continued)
  • 5. List for DTC Genetic Testing (continued)
  • 6. FDA's Warning Letters to Manufacturers
  • 7. List of Approved Companion Diagnostic Kits
  • 8. List of Approved Companion Diagnostic Kits (continued)
  • 9. Legal Disclaimer

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition-Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top